Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology Supplements
Published in: Clinical Research in Cardiology Supplements 1/2016

Open Access 01-03-2016

Rehabilitationsstandards für die Anschlussheilbehandlung und allgemeine Rehabilitation von Patienten mit einem Herzunterstützungssystem (VAD – ventricular assist device)

Authors: Dr. med. Detlev Willemsen, C. Cordes, B. Bjarnason-Wehrens, E. Knoglinger, E. Langheim, R. Marx, N. Reiss, T. Schmidt, A. Workowski, P. Bartsch, C. Baumbach, C. Bongarth, H. Phillips, R. Radke, M. Riedel, S. Schmidt, E. Skobel, C. Toussaint, J. Glatz

Published in: Clinical Research in Cardiology Supplements | Special Issue 1/2016

Login to get access

Abstract

The increasing use of ventricular assist devices (VADs) in terminal heart failure patients provides new challenges to cardiac rehabilitation physicians. Structured cardiac rehabilitation strategies are still poorly implemented for this special patient group. Clear guidance and more evidence for optimal modalities are needed. Thereby, attention has to be paid to specific aspects, such as psychological and social support and education (e.g., device management, INR self-management, drive-line care, and medication).
In Germany, the post-implant treatment and rehabilitation of VAD Patients working group was founded in 2012. This working group has developed clear recommendations for the rehabilitation of VAD patients according to the available literature. All facets of VAD patients’ rehabilitation are covered. The present paper is unique in Europe and represents a milestone to overcome the heterogeneity of VAD patient rehabilitation.
Appendix
Available only for authorised users
Literature
1.
2.
3.
4.
5.
6.
7.
Kirklin J, Naftel D, Pagani F, Kormos R, Stevenson L, Blume E, Miller M, Timothy Baldwin J, Young J (2014) Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant 33(6):555–564PubMedCrossRef
8.
Franke I (2014) Kreislaufunterstützungssysteme: Auf dem Weg zum Dauereinsatz. Dtsch Arztebl Int 111(1–2):A-31–A-32
9.
Workowski A, Willemsen D (2015) Befragung der kardiologischen Rehabilitationseinrichtungen in Deutschland. Nicht publizierte Statistik (für den AK-VAD). Bad Rothenfelde
10.
Corrà U, Pistono M, Mezzani A, Gnemmi M, Tarro Genta F, Caruso R, Giannuzzi P (2011) Cardiovascular prevention and rehabilitation for patients with ventricular assist device from exercise therapy to long-term therapy. Part I: exercise therapy. Monaldi Arch Chest Dis 76(1):27–32PubMed
11.
Pistono M, Corrà U, Gnemmi M, Imparato A, Caruso R, Balestroni G, Tarro Genta F, Angelino E, Giannuzzi P (2011) Cardiovascular prevention and rehabilitation for patients with ventricular assist device from exercise therapy to long-term therapy. Part II: long-term therapy. Monaldi Arch Chest Dis 76(3):136–145PubMed
12.
Vanhees L, Rauch B, Piepoli M, van Buuren F, Takken T, Borjesson M, Bjarnason-Wehrens B, Doherty P, Dugmore D, Halle M (2012) Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular disease (Part III). Eur J Prev Cardiol 19(6):1333–1356PubMedCrossRef
13.
Feldman D, Pamboukian S, Teuteberg J, Birks E, Lietz K, Moore S, Morgan J, Arabia F, Bauman M, Buchholz H, Deng M, Dickstein M, El-Banayosy A, Elliot T, Goldstein D, Grady K, Jones K, Hryniewicz K, John R, Kaan A, Kusne S, Loebe M, Massicotte M, Moazami N, Mohacsi P, Mooney M, Nelson T, Pagani F, Perry W, Potapov E, Eduardo Rame J, Russell S, Sorensen E, Sun B, Strueber M, Mangi A, Petty M, Rogers J (2013) The 2013 International Society for heart and lung transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant 32(2):157–187PubMedCrossRef
14.
15.
Pinkster I, Burgt B, Janssen D, Veenendaal E (2004) Successful test management. An Integral Approach. Springer, DordrechtCrossRef
16.
17.
Gemeinsamer Bundesausschuss (BA) (2014) Richtlinie des Gemeinamen Bundesausschusses über Leistungen zur medizinischen Rehabilitation. vom 16. März 2004, zuletzt geändert am 17. April 2014. Bundesanzeiger BAnz AT 26. Juni 2014 B4
18.
Collin C (2003) Measurement of disabillity and handicap. In: Greenwood R (Hrsg) Handbook of neurological rehabilitation. Psychology Press, Hove
19.
20.
21.
22.
23.
Nolan JP, Soar J, Zideman DA, Biarent D, Bossaert LL, Deakin C, Koster RW, Wyllie J, Böttiger B (2010) European resuscitation council guidelines for resuscitation 2010 Section 1. Executive summary. Resuscitation 81(10):1219–1276PubMedCrossRef
24.
Pagani F, Miller L, Russell S, Aaronson K, John R, Boyle A, Conte J, Bogaev R, MacGillivray T, Naka Y, Mancini D, Massey H, Chen L, Klodell C, Aranda J, Moazami N, Ewald G, Farrar D, Frazier O (2009) Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54(4):312–321PubMedCrossRef
25.
Fang J (2009) Rise of the machines – left ventricular assist devices as permanent therapy for advanced heart failure. N Engl J Med 361(23):2282–2285PubMedCrossRef
26.
HeartWare® Inc (2009) Heart Ware – Ventrikuläres Unterstützungssystem. Gebrauchsanweisung
27.
Slaughter M, Pagani F, McGee E, Birks E, Cotts W, Gregoric I, Howard Frazier O, Icenogle T, Najjar S, Boyce S, Acker M, John R, Hathaway D, Najarian K, Aaronson K (2013) HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant 32(7):675–683PubMedCrossRef
28.
Slaughter M, Pagani F, Rogers J, Miller L, Sun B, Russell S, Starling R, Chen L, Boyle A, Chillcott S, Adamson R, Blood M, Camacho M, Idrissi K, Petty M, Sobieski M, Wright S, Myers T, Farrar D (2010) Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 29(4):S1–S39PubMedCrossRef
29.
Strueber M, O’Driscoll G, Jansz P, Khaghani A, Levy W, Wieselthaler G (2011) Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 57(12):1375–1382PubMedCrossRef
30.
Thoratec Corporation (2008) HeartMate II® LVAS: instructions for use. Thoratec Corporation, Pleasanton
31.
32.
Thoratec Corporation per Mailkontakt zugeschickte und zur Veröffentlichung freigegebene Bilddatei – Reprinted with the permission of Thoratec Corporation. Zugegriffen: 20. August 2015
33.
HeartWare® Inc. per Mailkontakt zugeschickte und zur Veröffentlichung freigegebene Bilddateien. 10.8.2015
34.
35.
Hatano M, Kinugawa K, Shiga T, Kato N, Endo M, Hisagi M, Nishimura T, Yao A, Hirata Y, Kyo S, Ono M, Nagai R (2011) Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device. Circ J 75(5):1147–1155PubMedCrossRef
36.
Mezzani A, Pistono M, Corrà U, Giordano A, Gnemmi M, Imparato A, Centofanti P, Rinaldi M, Colombo S, Canal E, Giannuzzi P (2014) Systemic perfusion at peak incremental exercise in left ventricular assist device recipients: partitioning pump and native left ventricle relative contribution. IJC Heart Vessels 4:40–45CrossRef
37.
Myers T, Bolmers M, Gregoric I, Kar B, Frazier O (2009) Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant 28(5):423–427PubMedCrossRef
38.
Ammar K, Umland M, Kramer C, Sulemanjee N, Jan M, Khandheria B, Seward J, Paterick T (2012) The ABCs of left ventricular assist device echocardiography: a systematic approach. Eur Heart J Cardiovasc Imaging 13(11):885–899PubMedCrossRef
39.
Buck T, Breithardt O, Faber L, Fehske W, Flachskampf F, Franke A, Hagendorff A, Hoffmann R, Kruck I, Kücherer H, Menzel T, Pethig K, Tiemann K, Voigt J, Weidemann F, Nixdorff U (2009) Manual zur Indikation und Durchführung der Echokardiographie. Clin Res Cardiol Suppl 4(S1):3–51CrossRef
40.
Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P, Picard M, Roman M, Seward J, Shanewise J, Solomon S, Spencer K, St John Sutton M, Stewart W (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echo 18(12):1440–1463CrossRef
41.
Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA (2002) Recommendations for quantification of Doppler echocardiography. A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15(2):167–184PubMedCrossRef
42.
Kirkpatrick J, Wiegers S, Lang R (2010) Left ventricular assist devices and other devices for end-stage heart failure: utility of echocardiography. Curr Cardiol Rep 12(3):257–264PubMedCrossRef
43.
Rasalingam R, Johnson S, Bilhorn K, Huang P, Makan M, Moazami N, Pérez J (2011) Transthoracic echocardiographic assessment of continuous-flow left ventricular assist devices. J Am Soc Echo 24(2):135–148CrossRef
44.
Topilsky Y, Maltais S, Oh J, Atchison F, Perrault L, Carrier M, Park S (2011) Focused review on transthoracic echocardiographic assessment of patients with continuous axial left ventricular assist devices. Cardiol Res Pract 2011:1–11CrossRef
45.
Topilsky Y, Oh J, Atchison F, Shah D, Bichara V, Schirger J, Kushwaha S, Pereira N, Park S (2011) Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices. J Am Soc Echo 24(2):157–169CrossRef
46.
Stainback RF, Estep JD, Agler DA, Birks EJ, Bremer M, Hung J, Kirkpatrick JN, Rogers JG, Shah NR (2015) Echocardiography in the management of patients with left ventricular assist devices: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 28(8):853–909PubMedCrossRef
47.
Martina JR, Westerhof BE, van Goudoever J, Jonge N de, van Lieshout JJ, Lahpor JR, De Mol BAJM (2010) Noninvasive blood pressure measurement by the Nexfin monitor during reduced arterial pulsatility. A feasibility study. ASAIO J 56(3):221–227PubMedCrossRef
48.
Lanier G, Orlanes K, Hayashi Y, Murphy J, Flannery M, Te-Frey R, Uriel N, Yuzefpolskaya M, Mancini D, Naka Y, Takayama H, Jorde U, Demmer R, Colombo P (2013) Validity and reliability of a novel slow cuff-deflation system for noninvasive blood pressure monitoring in patients with continuous-flow left ventricular assist device. Circ Heart Fail 6(5):1005–1012PubMedCrossRef
49.
McMurray J, Adamopoulos S, Anker S, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez M, Jaarsma T, Kober L, Lip G, Maggioni A, Parkhomenko A, Pieske B, Popescu B, Ronnevik P, Rutten F, Schwitter J, Seferovic P, Stepinska J, Trindade P, Voors A, Zannad F, Zeiher A, Bax J, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes P, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet L, Avraamides P, Ben Lamin H, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf F, Guida G, Hardman S, Iung B, Merkely B, Mueller C, Nanas J, Nielsen O, Orn S, Parissis J, Ponikowski P (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847PubMedCrossRef
50.
Scheiderer R, Belde C, Schwab D, Haney C, Praz J (2013) Exercise guidelines for inpatients following ventricular assist device placement: a systematic review of the literature. Cardiopulm Phys Ther J 24(12):35–42PubMedCentralPubMed
51.
52.
Corrà U, Piepoli MF, Adamopoulos S, Agostoni P, Coats AJS, Conraads V, Lambrinou E, Pieske B, Piotrowicz E, Schmid J-P, Seferović PM, Anker SD, Filippatos G, Ponikowski PP (2014) Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC. Eur J Heart Fail 16(9):929–941PubMedCrossRef
53.
Loyaga-Rendon RY, Plaisance EP, Arena R, Shah K (2015) Exercise physiology, testing, and training in patients supported by a left ventricular assist device. J Heart Lung Transplant 34(8):1005–1016PubMedCrossRef
54.
American Thoracic Society (ATS) (2002) ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117CrossRef
55.
Podsiadlo D, Richardson S (1991) The timed „Up & Go“. A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142–148PubMedCrossRef
56.
Wonisch M, Hofmann P, Pokan R, Kraxner W, Hödl R, Maier R, Watzinger N, Smekal G, Klein W, Fruhwald F (2003) Spiroergometrie in der Kardiologie – Grundlagen der Physiologie und Terminologie. J Kardiol 10(9):383–390
57.
Fess E (1982) The effect of Jamar dynamometer handle position and test protocol on normal grip strength. J Hand Surg Am 7:308–309CrossRef
58.
Marschall F, Gail S (2011) Standardisierung eines Testprotokolls zur Bestimmung der isometrischen Maximalkraft. Beweg Gesundh 27(06):226–230CrossRef
59.
Krabatsch T, Potapov E, Soltani S, Dandel M, Falk V, Knosalla C (2015) Ventrikuläre Langzeitunterstützung mit implantierbaren kontinuierlichen Flusspumpen. Auf dem Weg zum Goldstandard in der Therapie der terminalen Herzinsuffizienz. Herz 40(2):231–239PubMedCrossRef
60.
Vierecke J, Kaufmann F, Schweiger M, Stepanenko A, Dranishnikov N, Lehmkuhl H, Potapov E, Hetzer R, Krabatsch T (2011) Erste Maßnahmen und Verhalten bei Störungen eines Kunstherzsystems. Notfall Rettungsmed 14(8):635–646CrossRef
61.
Wilson SR, Givertz MM, Stewart GC, Mudge GH (2009) Ventricular assist devices the challenges of outpatient management. J Am Coll Cardiol 54(18):1647–1659PubMedCrossRef
62.
Garan A, Iyer V, Whang W, Mody K, Yuzefpolskaya M, Colombo P, Te-Frey R, Takayama H, Naka Y, Garan H, Jorde U, Uriel N (2014) Catheter ablation for ventricular tachyarrhythmias in patients supported by continuous-flow left ventricular assist devices. ASAIO J 60(3):311–316PubMedCrossRef
63.
Herweg B, Ilercil A, Kristof-Kuteyeva O, Rinde-Hoffman D, Caldeira C, Mangar C, Karlinosky R, Barold S (2012) Clinical observations and outcome of ventricular tachycardia ablation in patients with left ventricular assist devices. Pacing Clin Electrophysiol 35(11):1377–1383PubMedCrossRef
64.
Slaughter M, Rogers J, Milano C, Russell S, Conte J, Feldman D, Sun B, Tatooles A, Delgado R, Long J, Wozniak T, Ghumman W, Farrar D, Frazier O (2009) Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361(23):2241–2251PubMedCrossRef
65.
Oswald H, Klein G, Strüber M, Gardiwal A (2009) Implantable defibrillator with left ventricular assist device compatibility. Interact Cardiovasc Thorac Surg 8(5):579–580PubMedCrossRef
66.
Oswald H, Schultz-Wildelau C, Gardiwal A, Lüsebrink U, König T, Meyer A, Duncker D, Pichlmaier MA, Klein G, Strüber M (2010) Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail 12(6):593–599PubMedCrossRef
67.
Pecha S, Wilke I, Bernhardt A, Hakmi S, Yildirim Y, Steven D, Reichenspurner H, Willems S, Deuse T, Aydin A (2014) Clinical experience of combined HeartWare ventricular assist device and implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol 25(10):1109–1114PubMedCrossRef
68.
Andersen M, Videbæk R, Boesgaard S, Sander K, Hansen P, Gustafsson F (2009) Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant 28(7):733–735PubMedCrossRef
69.
Refaat M, Tanaka T, Kormos R, Mcnamara D, Teuteberg J, Winowich S, London B, Simon M (2012) Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device supported heart failure patients. J Cardiac Fail 18(2):140–145CrossRef
70.
Enriquez A, Calenda B, Miller M, Anyanwu A, Pinney S (2013) The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol 6(4):668–674PubMedCrossRef
71.
Cantillon D, Tarakji K, Kumbhani D, Smedira N, Starling R, Wilkoff B (2010) Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm 7(4):466–471PubMedCrossRef
72.
Garan A, Yuzefpolskaya M, Colombo P, Morrow J, Te-Frey R, Dano D, Takayama H, Naka Y, Garan H, Jorde U, Uriel N (2013) Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices. J Am Coll Cardiol 61(25):2542–2550PubMedCrossRef
73.
Pettit S, Petrie M, Connelly D, Japp A, Payne J, Haj-Yahia S, Gardner R (2012) Use of implantable cardioverter defibrillators in patients with left ventricular assist devices. Eur J Heart Fail 14(7):696–702PubMedCrossRef
74.
Muratsu J, Hara M, Mizote I, Asano Y, Sakata Y, Saito S, Matsumiya G, Sawa Y, Komuro I (2011) The impact of cardiac resynchronization therapy in an end-stage heart failure patient with a left ventricular assist device as a bridge to recovery. Int Heart J 52(4):246–247PubMedCrossRef
75.
Ambardekar A, Lowery C, Allen L, Cannon A, Cleveland J, Lindenfeld J, Brieke A, Sauer W (2010) Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads. J Cardiac Fail 16(4):327–331CrossRef
76.
Moss A, Schuger C, Beck C, Brown M, Cannom D, Daubert J, Estes N, Greenberg H, Hall W, Huang D, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367(24):2275–2283PubMedCrossRef
77.
Reibis RK, Kamke W, Langheim E, Völler H (2010) Rehabilitation von Patienten mit Herzschrittmachern und Kardioverter-Defibrillatoren: Empfehlungen zu Training, Physiotherapie und beruflicher Wiedereingliederung. Dtsch Med Wochenschr 135(15):759–764PubMedCrossRef
78.
Volkmann H (2004) Störbeeinflussung von implantierten Herzschrittmachern im medizinischen Bereich. Herzschr Elektrophys 15(1):65–72CrossRef
79.
Meyer AL, Mohr F-W, Strüber M (2014) Update der kardialen Assistenzsysteme. Z Herz- Thorax- Gefäßchir 28(3):185–195CrossRef
80.
Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M (2010) Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 3(6):675–681PubMedCrossRef
81.
Potapov EV, Stepanenko A, Krabatsch T, Hetzer R (2011) Managing long-term complications of left ventricular assist device therapy. Curr Opin Cardiol 26(3):237–244PubMedCrossRef
82.
Teuteberg JJ, Kormos RL, Lockard K, Kunz N, Allen C, Scanlon A, Weaver S, Hall D, Bermudez C, Shullo MA (2013) Management of anticoagulation in patients with mechanical circulatory support using a physician-based versus a pharmacist directed anticoagulation clinic-based strategy. J Heart Lung Transplant 32(4):S294–S295CrossRef
83.
Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos SG (2012) Ventricular assist devices: pharmacological aspects of a mechanical therapy. Pharmacol Ther 134(2):189–199PubMedCentralPubMedCrossRef
84.
Rossi M, Serraino GF, Jiritano F, Renzulli A (2012) What is the optimal anticoagulation in patients with a left ventricular assist device? Interact Cardiovasc Thorac Surg 15(4):733–740PubMedCentralPubMedCrossRef
85.
Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O’Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E (2013) Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309(12):1268–1277PubMedCrossRef
86.
Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost A, Engel P, Kramer MR, Serdarevic-Pehar M, Layton GR, Sitbon O, Badesch DB (2014) Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension. J Heart Lung Transplant 33(7):689–697PubMedCrossRef
87.
Tedford RJ, Hemnes AR, Russell SD, Wittstein IS, Mahmud M, Zaiman AL, Mathai SC, Thiemann DR, Hassoun PM, Girgis RE, Orens JB, Shah AS, Yuh D, Conte JV, Champion HC (2008) PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail 1(4):213–219PubMedCentralPubMedCrossRef
88.
Milano C, Simeone A (2013) Mechanical circulatory support: devices, outcomes and complications. Heart Fail Rev 18(1):35–53PubMedCrossRef
89.
Hannan M, Husain S, Mattner F, Danziger-Isakov L, Drew R, Corey GR, Schueler S, Holman W, Lawler L, Gordon S, Mahon NG, Herre J, Gould K, Montoya J, Padera R, Kormos R, Conte J, Mooney M (2011) Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant 30(4):375–384PubMedCrossRef
90.
Pauwaa S, Bhat G (2011) Ventricular assist device-specific infections. In: Shuhaiber J (Hrsg) Ventricular assist devices. InTechOpen, Rijeka
91.
Holman WL, Rayburn BK, McGiffin DC, Foley BA, Benza RL, Bourge RC, Pinderski LJ, Kirklin JK (2003) Infection in ventricular assist devices. Prevention and treatment. Ann Thorac Surg 75(6):S48–S57PubMedCrossRef
92.
Sharma V, Deo S, Stulak J, Durham L, Daly R, Park S, Baddour L, Mehra K, Joyce L (2012) Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg 94(5):1381–1386.PubMedCrossRef
93.
Nienaber J, Kusne S, Riaz T, Walker R, Baddour L, Wright AJ, Park S, Vikram H, Keating M, Arabia F, Lahr B, Sohail M (2013) Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis 57(10):1438–1448PubMedCentralPubMedCrossRef
94.
Ruscher C (2014) Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 57(6):695–732CrossRef
95.
Garatti A, Giuseppe B, Russo C, Marco O, Ettore V (2007) Drive-line exit-site infection in a patient with axial-flow pump support: successful management using vacuum-assisted therapy. J Heart Lung Transplant 9(26):956–959CrossRef
96.
World Health Organization (2001) International classification of functioning, disability and health. ICF. WHO, Geneva
97.
Knoglinger E (2008) WHO-Klassifikation ICF: Grundlagen und Anwendbarkeit in der kardiologischen Rehabilitation. Herzmedizin 25:36–42
98.
Cieza A, Ewert T, Ustün TB, Chatterji S, Kostanjsek N, Stucki G (2004) Development of ICF Core Sets for patients with chronic conditions. J Rehabil Med (44 Suppl):9–11
99.
Wildner M, Quittan M, Portenier L, Wilke S, Boldt C, Stucki G, Kostanjsek N, Grill E (2005) ICF Core Set for patients with cardiopulmonary conditions in early post-acute rehabilitation facilities. Disabil Rehabil 27(7–8):397–404PubMedCrossRef
100.
101.
Schüle K, Huber G (2000) Grundlagen der Sporttherapie. Prävention, ambulante und stationäre Rehabilitation, 1. Aufl. Urban & Fischer, München
102.
Maybaum S, Mancini D, Xydas S, Starling RC, Aaronson K, Pagani FD, Miller LW, Margulies K, McRee S, Frazier OH, Torre-Amione G (2007) Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 115(19):2497–2505PubMedCrossRef
103.
Rogers J, Aaronson K, Boyle A, Russell S, Milano C, Pagani F, Edwards B, Park S, John R, Conte J, Farrar D, Slaughter M (2010) Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 55(17):1826–1834PubMedCrossRef
104.
Jung MH, Gustafsson F (2015) Exercise in heart failure patients supported with a left ventricular assist device. J Heart Lung Transplant 34(4):489–496PubMedCrossRef
105.
Humphrey R (1997) Exercise physiology in patients with left ventricular assist devices. J Cardpulm Rehabil 17(2):73–75CrossRef
106.
Piña I (2010) Cardiac rehabilitation in heart failure: a brief review and recommendations. Curr Cardiol Rep 12(3):223–229PubMedCrossRef
107.
Wells C (2013) Physical therapist management of patients with ventricular assist devices: key considerations for the acute care physical therapist. Phys Ther 93(2):266–278PubMedCrossRef
108.
Hayes K, Leet A, Bradley S, Holland A (2012) Effects of exercise training on exercise capacity and quality of life in patients with a left ventricular assist device: a preliminary randomized controlled trial. J Heart Lung Transplant 31(7):729–734PubMedCrossRef
109.
Karapolat H, Engin C, Eroglu M, Yagdi T, Zoghi M, Nalbantgil S, Durmaz B, Kirazlı Y, Ozbaran M (2013) Efficacy of the cardiac rehabilitation program in patients with end-stage heart failure, heart transplant patients, and left ventricular assist device recipients. Transplant Proc 45(9):3381–3385PubMedCrossRef
110.
Kohli H, Canada J, Arena R, Tang D, Peberdy M, Harton S, Flattery M, Doolin K, Katlaps G, Hess M, Kasirajan V, Shah K (2011) Exercise blood pressure response during assisted circulatory support: comparison of the total artifical heart with a left ventricular assist device during rehabilitation. J Heart Lung Transplant 30(11):1207–1213PubMedCrossRef
111.
Laoutaris I, Dritsas A, Adamopoulos S, Manginas A, Gouziouta A, Kallistratos M, Koulopoulou M, Voudris V, Cokkinos D, Sfirakis P (2011) Benefits of physical training on exercise capacity, inspiratory muscle function, and quality of life in patients with ventricular assist devices long-term postimplantation. Eur J Cardiovasc Prev Rehabil 18(1):33–40PubMed
112.
Marko C, Danzinger G, Käferbäck M, Lackner T, Müller R, Zimpfer D, Schima H, Moscato F (2014) Safety and efficacy of cardiac rehabilitation for patients with continuous flow left ventricular assist devices. Eur J Prev Cardiol 22(11):1378–1384PubMedCrossRef
113.
Nissinoff J, Tian F, Therattil M, Salvarrey R, Lee S (2011) Acute inpatient rehabilitation after left ventricular assist device implantation for congestive heart failure. PM R 3(6):586–589PubMedCrossRef
114.
Kugler C, Malehsa D, Schrader E, Tegtbur U, Guetzlaff E, Haverich A, Strueber M (2012) A multi-modal intervention in management of left ventricular assist device outpatients: dietary counselling, controlled exercise and psychosocial support. Eur J Cardiothorac Surg 42(6):1026–1032PubMedCrossRef
115.
Alsara O, Perez-Terzic C, Squires RW, Dandamudi S, Miranda WR, Park SJ, Thomas RJ (2014) Is exercise training safe and beneficial in patients receiving left ventricular assist device therapy? J Cardiopulm Rehabil Prev 34(4):233–240PubMedCrossRef
116.
Compostella L, Russo N, Setzu T, Bottio T, Compostella C, Tarzia V, Livi U, Gerosa G, Iliceto S, Bellotto F (2015) A practical review for cardiac rehabilitation professionals of continuous-flow left ventricle assist devices: historical and current perspectives. J Cardiopulm Rehabil Prev 35(5):301–311PubMedCrossRef
117.
Workowski A (2015) Kardiologische Rehabilitation von Patienten mit einem Herzunterstützungssystem. Dissertation, Deutsche Sporthochschule Köln
118.
Workowski A, Bartsch P, Stuhr H, Willemsen D, Bjarnason-Wehrens B (2014) Resistance training in patients with an intracorporal ventricular assist device (VAD) of the third generation during phase II cardiac rehabilitation (CR). Eur J Prev Cardiol 21:6
119.
Piepoli M, Conraads V, Corrà U, Dickstein K, Francis D, Jaarsma T, McMurray J, Pieske B, Piotrowicz E, Schmid J, Anker S, Solal A, Filippatos G, Hoes A, Gielen S, Giannuzzi P, Ponikowski P (2011) Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Europ J Heart Fail 13(4):347–357CrossRef
120.
121.
Roefe D, Schulz U (2014) „Ventricular-assist-device“-Koordination. Z Herz- Thorax- Gefäßchir 28(5):327–331CrossRef
122.
123.
Granger CV, Hamilton BB, Linacre JM, Heinemann AW, Wright BD (1993) Performance profiles of the functional independence measure. Am J Phys Med Rehabil 72(2):84–89PubMedCrossRef
124.
Internationale Vereinigung für Assessment in der Rehabilitation (IVAR) (Hrsg) FIM – Funktionale Selbständigkeitsmessung. Manual. 1. Version. Straubing 1997
125.
Shepherd J, Wilding C (2006) Occupational therapy for people with ventricular assist devices. Aust Occup Therap J 53(1):47–49CrossRef
126.
Albert W, Bittner A, Kiekbusch S, Buschtöns C, Gehringer A, Kinzel S, Hetzer R (2002) Das Kunstherz – eine extreme psychische Belastungssituation? Z Herz Thorax Gefasschir 16(1):I/110–I/119
127.
Bunzel B, Roethy W, Znoj H, Laederach-Hofmann K (2008) Psychological consequences of life-saving cardiac surgery in patients and partners: measurement of emotional stress by the Impact of Event Scale. Stress Health 24(5):351–363CrossRef
128.
Mapelli, D.; Cavazzana, A.; Cavalli, C.; Bottio, T.; Tarzia, V.; Gerosa, G.; Volpe, B. R.: Clinical psychological and neuropsychological issues with left ventricular assist devices (LVADs). In: Annals of cardiothoracic surgery 3 (2014) 5, S. 480–89.
129.
MacIver J, Ross H (2012) Quality of life and left ventricular assist device support. Circulation 126(7):866–874PubMedCrossRef
130.
Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435–1443PubMedCrossRef
131.
Brouwers C, Denollet J, De Jonge N, Caliskan K, Kealy J, Pedersen S (2011) Patient-reported outcomes in left ventricular assist device therapy: a systematic review and recommendations for clinical research and practice. Circ Heart Fail 4(6):714–723PubMedCrossRef
132.
Kugler C, Malehsa D, Tegtbur U, Guetzlaff E, Meyer A, Bara C, Haverich A, Strueber M (2011) Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study. J Heart Lung Transplant 30(2):204–210PubMedCrossRef
133.
Ladwig K, Lederbogen F, Albus C, Angermann C, Borggrefe M, Fischer D, Fritzsche K, Haass M, Jordan J, Jünger J, Kindermann I, Köllner V, Kuhn B, Scherer M, Seyfarth M, Völler H, Waller C, Herrmann-Lingen C (2013) Positionspapier zur Bedeutung psychosozialer Faktoren in der Kardiologie. Kardiologe 7(1):7–27CrossRef
134.
Petrucci R, Rogers J, Blue L, Gallagher C, Russell S, Dordunoo D, Jaski B, Chillcott S, Sun B, Yanssens T, Tatooles A, Koundakjian L, Farrar D, Slaughter M (2012) Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support. J Heart Lung Transplant 31(1):27–36PubMedCrossRef
135.
Kirklin J, Naftel D, Kormos R, Stevenson L, Pagani F, Miller M, Timothy Baldwin J, Young J (2013) Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 32(2):141–156PubMedCrossRef
136.
Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof DA, Kormos RL, Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park SJ (2014) Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 63(17):1751–1757PubMedCrossRef
137.
Herrmann-Lingen C, Buss U, Snaith R (2011) HADS-D – Hopital Anxiety and Depression Scale – Deutsche Version. 3. aktualisierte und neu normierte Aufl. Hogrefe, Bern
138.
Bullinger M, Kirchberger I (1998) Medical outcomes study Short-Form General Health Survey SF-36 manual (German version). Göttingen
139.
Graf J-M, Claes C, Greiner W, Uber A (1998) Die deutsche Version des EuroQol-Fragebogens. J Public Health 6(1):3–20CrossRef
140.
Rabin R, Charro F de (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33(5):337–343PubMedCrossRef
141.
Faller H, Steinbüchel T, Schowalter M, Spertus JA, Störk S, Angermann CE (2005) Der Kansas City Cardiomyopathy Questionnaire (KCCQ) – ein neues krankheitsspezifisches Messinstrument zur Erfassung der Lebensqualität bei chronischer Herzinsuffizienz – Psychometrische Prüfung der deutschen Version. Psychother Psychosom Med Psychol 55(3–4):200–208PubMedCrossRef
142.
Green C, Porter CB, Bresnahan DR, Spertus JA (2000) Development and evaluation of the Kansas City Cardiomyopathy Questionnaire. A new health status measure for heart failure. J Am Coll Cardiol 35(5):1245–1255PubMedCrossRef
143.
Middel B, Bouma J, Jongste M de, van Sonderen E, Niemeijer MG, Crijns H, van den Heuvel W (2001) Psychometric properties of the Minnesota Living with Heart Failure Questionnaire (MLHF-Q). Clin Rehabil 15(5):489–500PubMedCrossRef
144.
Quittan M, Wiesinger GF, Crevenna R, Nuhr MJ, Posch M, Hülsmann M, Müller D, Pacher R, Fialka-Moser V (2001) Cross-cultural adaptation of the Minnesota Living with Heart Failure Questionnaire for German-speaking patients. J Rehabil Med 33(4):182–186PubMedCrossRef
145.
Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW (2007) Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116(5):497–505PubMedCrossRef
146.
Dang N, Topkara V, Kim B, Lee B, Remoli R, Naka Y (2005) Nutritional status in patients on left ventricular assist device support. J Thorac Cardiovasc Surg 130(5):e3–e4PubMedCrossRef
147.
John R, Lietz K, Schuster M, Naka Y, Rao V, Mancini DM, Rose EA, Smith CR, Oz MC, Edwards NM, Itescu S (2003) Immunologic sensitization in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg 125(3):578–591PubMedCrossRef
148.
Mano A, Fujita K, Uenomachi K, Kazama K, Katabuchi M, Wada K, Terakawa N, Arai K, Hori Y, Hashimoto S, Nakatani T, Kitamura S (2009) Body mass index is a useful predictor of prognosis after left ventricular assist system implantation. J Heart Lung Transplant 28(5):428–433PubMedCrossRef
149.
Evans W, Morley J, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch W, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker S (2008) Cachexia: a new definition. Clin Nutr 27(6):793–799PubMedCrossRef
150.
151.
Anker SD, Negassa A, Coats AJS, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors. An observational study. Lancet 361(9363):1077–1083PubMedCrossRef
152.
Lietz K, John R, Burke EA, Ankersmit JH, McCue JD, Naka Y, Oz MC, Mancini DM, Edwards NM (2001) Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation1. Transplantation 72(2):277–283PubMedCrossRef
153.
McMurray J, Petrie M, Swedberg K, Komajda M, Anker S, Gardner R (2009) Heart failure. In: Camm A, Lüscher T, Serruys P (Hrsg) The ESC textbook of cardiovascular medicine. Oxford University Press, Rotterdam
154.
Sandek A, Doehner W, Anker SD, Haehling S von (2009) Nutrition in heart failure: an update. Curr Opin Clin Nutr Metab Care 12(4):384–391PubMedCrossRef
155.
Montgomery T, Cohen A, Garnick J, Spadafore J, Boldea E (2012) Nutrition assessment, care, and considerations of ventricular assist device patients. Nutr Clin Pract 27(3):352–362PubMedCrossRef
156.
Akashi YJ, Springer J, Anker SD (2005) Cachexia in chronic heart failure. Prognostic implications and novel therapeutic approaches. Curr Heart Fail Rep 2(4):198–203PubMedCrossRef
157.
Pasini E, Opasich C, Pastoris O, Aquilani R (2004) Inadequate nutritional intake for daily life activity of clinically stable patients with chronic heart failure. Am J Cardiol 93(8A):41A–43APubMedCrossRef
158.
159.
160.
Creutzberg EC, Wouters EFM, Mostert R, Pluymers RJ, Schols AMWJ (2003) A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Chest 124(5):1733–1742PubMedCrossRef
161.
Slaughter MS, Pappas P, Tatooles A (2003) Percutaneous endoscopic gastrostomy tube in a patient with a left ventricular assist device. ASAIO J 49(5):611–612PubMedCrossRef
162.
Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313PubMedCrossRef
163.
Yancy C, Jessup M, Bozkurt B, Butler J, Casey D, Drazner M, Fonarow G, Geraci S, Horwich T, Januzzi J, Johnson M, Kasper E, Levy W, Masoudi F, McBride P, McMurray J, Mitchell J, Peterson P, Riegel B, Sam F, Stevenson L, Tang W, Tsai E, Wilkoff B (2013) 2013 AHA guideline for the management of heart failure. J Am Coll Cardiol 62(16):e147–e239PubMedCrossRef
164.
Habbu A, Lakkis NM, Dokainish H (2006) The obesity paradox: fact or fiction? Am J Cardiol 98(7):944–948PubMedCrossRef
165.
Musci M, Loforte A, Potapov EV, Krabatsch T, Weng Y, Pasic M, Hetzer R (2008) Body mass index and outcome after ventricular assist device placement. Ann Thorac Surg 86(4):1236–1242PubMedCrossRef
166.
Klodell CT, Staples ED, Aranda JM, Schofield RS, Hill JA, Pauly DF, Beaver TM (2006) Managing the post-left ventricular assist device patient. Congest Heart Fail 12(1):41–45PubMedCrossRef
167.
168.
Hiestand B (2009) Circulatory assist devices in heart failure patients. Heart Fail Clin 5(1):55–62PubMedCrossRef
169.
170.
Universität Leipzig – Herzzentrum (2015) Kunstherz-Patientenführerschein
171.
Corra U, Pistono M, Piepoli MF, Giannuzzi P (2012) Ventricular assist device patients on the horizon of cardiovascular prevention and rehabilitation. Can we convert challenges into opportunities? Eur J Prev Cardiol 19(3):490–493PubMedCrossRef
172.
Egerod I, Overgaard D (2012) Taking a back seat: support and self-preservation in close relatives of patients with left ventricular assist device. Eur J Cardiovasc Nurs 11(4):380–387PubMedCrossRef
173.
Nguyen E, Stein J (2013) Functional outcomes of adults with left ventricular assist devices receiving inpatient rehabilitation. PM R 5(2):99–103PubMedCrossRef
174.
Ambardekar A, Cannon A, Cleveland J, Brieke A, Lindenfeld J (2011) Driving with a driveline: a survey of current practice patterns for allowing a patient supported with a left ventricular assist device to drive. J Heart Lung Transplant 30(10):1204–1205PubMedCrossRef
175.
Thoratec Corporation (2011) Heart Mate II community living manual: your guide to successful LVAS patient discharges. Thoracec Corp, Pleasanton
176.
Emani S, O’Keefe C, Wissman S, MacBrair K, White L, Hasan A, Sai-Sudhakar C, Sun B (2011) 190 Driver’s education: a single center experience on the incidence and safety of driving with LVADS. J Heart Lung Transplant 30(4):S70CrossRef
177.
Emani S, Pagani F, Eckman P, Gordon R, Brisco M, Klodell C, Mandras S, Hasan A, Sai-Sudhakar C, Sun B (2013) Hit the road: a multicenter evaluation of driving with LVADs. J Heart Lung Transplant 32(4):S98CrossRef
178.
Klein H, Krämer A, Pieske B, Trappe H, De Vries H (2010) Fahreignung bei kardiovaskulären Erkrankungen. Kardiologe 4(6):441–473CrossRef
179.
Golka K, Hengstler JG (Hrsg) (2011) Verkehrsmedizin – arbeitsmedizinische Aspekte. Orientierungshilfe für Praxis, Klinik und Betrieb; Schwerpunktthema Jahrestagung DGAUM 2010. ecomed, Heidelberg
180.
Madea B, Abel R (Hrsg) (2012) Verkehrsmedizin. Fahreignung, Fahrsicherheit, Unfallrekonstruktion; mit 128 Tabellen. Deutscher Ärzte-Verlag, Köln
181.
Baskett R, Crowell R, Freed D, Giannetti N, Simpson C (2012) Canadian Cardiovascular Society focused position statement update on assessment of the cardiac patient for fitness to drive: fitness following left ventricular assist device implantation. Can J Cardiol 28(2):137–140PubMedCrossRef
182.
Gräcmann N, Albrecht M Begutachtungsleitlinien zur Kraftfahreignung. Berichte der Bundesanstalt für Straßenwesen, Mensch und Sicherheit Heft M 115, gültig ab 1. Mai 2014. Bergisch Gladbach 2014
183.
Coyle L, Martin M, Kurien S, Graham J, Gallagher C, Silver M, Slaughter M (2008) Destination therapy: safety and feasibility of national and international travel. ASAIO J 54(2):172–176PubMedCrossRef
184.
Lufthansa Operation Center, m. 0.-5., mündliche Information
185.
186.
Park S, Milano C, Tatooles A, Rogers J, Adamson R, Steidley D, Ewald G, Sundareswaran K, Farrar D, Slaughter M (2012) Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 5(2):241–248PubMedCrossRef
187.
Bunzel B, Laederach-Hofmann K, Wieselthaler G, Roethy W, Wolner E (2007) Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional sequelae in patients and spouses. J Heart Lung Transplant 26(4):384–389PubMedCrossRef
188.
Dev S, Abernethy A, Rogers J, O’Connor C (2012) Preferences of people with advanced heart failure – a structured narrative literature review to inform decision making in the palliative care setting. Am Heart J 164(3):313–319.e5PubMedCrossRef
189.
Bruce C, Smith M, McCullough L (2013) Clarification of the intent of ventricular assist devices before patient consent. J Thorac Cardiovasc Surg 145(6):1423–1425PubMedCrossRef
190.
Bramstedt K, Chalfant A, Wright C (2007) Emergency consults in the setting of transplant medicine. Dilemmas for social workers and bioethicists. Prog Transplant 17(1):36–39PubMedCrossRef
191.
Bruce C, Bhimaraj A, Smith M (2014) Revisiting surrogate consent for ventricular assist device placement. Ann Thorac Surg 97(3):747–749PubMedCrossRef
192.
Brush S, Budge D, Alharethi R, McCormick A, MacPherson J, Reid B, Ledford I, Smith H, Stoker S, Clayson S, Doty J, Caine W, Drakos S, Kfoury A (2010) End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant 29(12):1337–1341PubMedCrossRef
193.
Tanner C, Fromme E, Goodlin S (2011) Ethics in the treatment of advanced heart failure: palliative care and end-of-life issues. Congest Heart Fail 17(5):235–240PubMedCrossRef
194.
Adler E, Goldfinger J, Kalman J, Park M, Meier D (2009) Palliative care in the treatment of advanced heart failure. Circulation 120(25):2597–2606PubMedCrossRef
195.
Kini V, Kirkpatrick J (2013) Ethical challenges in advanced heart failure. Curr Opin Support Palliat Care 7(1):21–28PubMedCrossRef
196.
Swetz K, Freeman M, AbouEzzeddine O, Carter K, Boilson B, Ottenberg A, Park S, Mueller P (2011) Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc 86(6):493–500PubMedCentralPubMedCrossRef
197.
Gerhard C et al (2012) Arbeitspapier der AG Nicht-Tumorpatienten – Palliativversorgung bei Herzinsuffizienz. Z Palliativmed 13(02):61–63CrossRef
198.
Jaarsma T, Beattie J, Ryder M, Rutten F, McDonagh T, Mohacsi P, Murray S, Grodzicki T, Bergh I, Metra M, Ekman I, Angermann C, Leventhal M, Pitsis A, Anker S, Gavazzi A, Ponikowski P, Dickstein K, Delacretaz E, Blue L, Strasser F, McMurray J (2009) Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11(5):433–443PubMedCrossRef
199.
Bruce CR, Brody B, Majumder MA (2013) Ethical dilemm as surrounding the use of ventricular assist devices in supporting patients with end-stage organ dysfunction. Methodist Debakey Cardiovasc J 9(1):11–14PubMedCentralPubMedCrossRef
200.
Rizzieri A, Verheijde J, Rady M, McGregor J (2008) Ethical challenges with the left ventricular assist device as a destination therapy. Philos Ethics Humanit Med 3(1):20PubMedCentralPubMedCrossRef
201.
Bundesärztekammer (2011) Grundsätze der Bundesärztekammer zur ärztlichen Sterbebegleitung. Dtsch Arztebl 108(7):A346–A348
202.
Bramstedt K (2008) Destination nowhere: a potential dilemma with ventricular assist devices. ASAIO J 54(1):1–2PubMedCrossRef
203.
Mueller P, Swetz K, Freeman M, Carter K, Crowley M, Severson C, Park S, Sulmasy D (2010) Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc 85(9):791–797PubMedCentralPubMedCrossRef
204.
Gafford E, Luckhardt A, Swetz K (2013) Deactivation of a left ventricular assist device at the end of life #269. J Palliat Med 16(8):980–982PubMedCrossRef
Metadata
Title
Rehabilitationsstandards für die Anschlussheilbehandlung und allgemeine Rehabilitation von Patienten mit einem Herzunterstützungssystem (VAD – ventricular assist device)
Authors
Dr. med. Detlev Willemsen
C. Cordes
B. Bjarnason-Wehrens
E. Knoglinger
E. Langheim
R. Marx
N. Reiss
T. Schmidt
A. Workowski
P. Bartsch
C. Baumbach
C. Bongarth
H. Phillips
R. Radke
M. Riedel
S. Schmidt
E. Skobel
C. Toussaint
J. Glatz
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology Supplements / Issue Special Issue 1/2016
Print ISSN: 1861-0706
Electronic ISSN: 1861-0714
DOI
https://doi.org/10.1007/s11789-015-0077-x

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits